Hepatocellular Carcinoma (HCC) represents the fifth most common malignancy and the third cancer-related cause of death worldwide. Liver transplantation (LT) is an excellent treatment for patients with small HCC associated with cirrhosis. The purpose of this review is to investigate the possible strategies for the treatment of HCC recurrence after LT based on current clinical evidence.
Multimodal oncological approach in patients affected by recurrent hepatocellular carcinoma after liver transplantation / Guerrini, Gp; Berretta, M; Tarantino, G; Magistri, P; Pecchi, A; Ballarin, R; Di Benedetto, F. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 2284-0729. - 21:15(2017), pp. 3421-3435.
Multimodal oncological approach in patients affected by recurrent hepatocellular carcinoma after liver transplantation
Tarantino G;Magistri P;Pecchi A;Di Benedetto F
2017
Abstract
Hepatocellular Carcinoma (HCC) represents the fifth most common malignancy and the third cancer-related cause of death worldwide. Liver transplantation (LT) is an excellent treatment for patients with small HCC associated with cirrhosis. The purpose of this review is to investigate the possible strategies for the treatment of HCC recurrence after LT based on current clinical evidence.
| File | Dimensione | Formato | |
|---|---|---|---|
|
2017 -Multimodal oncological approach.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
512.23 kB
Formato
Adobe PDF
|
512.23 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
